Fux CA - Search Results

1

A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, van Straalen JP, Furrer H, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. Among authors: fux ca. Clin Nephrol. 2012 Apr;77(4):311-20. doi: 10.5414/cn107214. Clin Nephrol. 2012. PMID: 22445475 Clinical Trial.

2

Opportunistic infections: an update.

Furrer H, Fux C. Furrer H, et al. J HIV Ther. 2002 Feb;7(1):2-7. J HIV Ther. 2002. PMID: 11956497 Review.

3

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.

Wunder DM, Bersinger NA, Fux CA, Mueller NJ, Hirschel B, Cavassini M, Elzi L, Schmid P, Bernasconi E, Mueller B, Furrer H; Swiss HIV Cohort Study. Wunder DM, et al. Among authors: fux ca. Antivir Ther. 2007;12(2):261-5. Antivir Ther. 2007. PMID: 17503668

4

Effect of tenofovir on renal glomerular and tubular function.

Fux CA, Christen A, Zgraggen S, Mohaupt MG, Furrer H. Fux CA, et al. AIDS. 2007 Jul 11;21(11):1483-5. doi: 10.1097/QAD.0b013e328216f15b. AIDS. 2007. PMID: 17589197

5

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

Fux CA, Simcock M, Wolbers M, Bucher HC, Hirschel B, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Elzi L, Furrer H; Swiss HIV Cohort Study. Fux CA, et al. Antivir Ther. 2007;12(8):1165-73. Antivir Ther. 2007. PMID: 18240857

6

Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.

Fux CA, Rauch A, Simcock M, Bucher HC, Hirschel B, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Elzi L, Furrer H; Swiss HIV Cohort Study. Fux CA, et al. Antivir Ther. 2008;13(8):1077-82. Antivir Ther. 2008. PMID: 19195333

7

Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?

Fux CA, Baumann S, Furrer H, Mueller NJ. Fux CA, et al. AIDS. 2011 Mar 27;25(6):876-8. doi: 10.1097/QAD.0b013e32834544af. AIDS. 2011. PMID: 21412066 No abstract available.

8

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Furrer H, Brinkman K, Hoek FJ, Abeling NG, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. Among authors: fux ca. AIDS. 2011 Nov 13;25(17):2149-55. doi: 10.1097/QAD.0b013e32834bba87. AIDS. 2011. PMID: 21857491

9

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.

Young J, Schäfer J, Fux CA, Furrer H, Bernasconi E, Vernazza P, Calmy A, Cavassini M, Weber R, Battegay M, Bucher HC; Swiss HIV Cohort Study. Young J, et al. Among authors: fux ca. AIDS. 2012 Mar 13;26(5):567-75. doi: 10.1097/QAD.0b013e32834f337c. AIDS. 2012. PMID: 22398568

10

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group. Ryom L, et al. Among authors: fux ca. J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4. J Infect Dis. 2013. PMID: 23382571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters